You stand on the sidelines commenting on a stock for 12 months whilst it does a Disallowed? Please send me the details of your strategy, I would love to hedge against it.
Btw, some months ago, I sold a decent chunk of my PNV (one of your pin up boys) shares at 2.60 which I bought in 1.20s (about a year ago). That's how you trade slower growth, overvalued biotechs, as an investor. You don't sell 1st time breakthrough approval biotechs with multi blockbusters in phase 3 or close to AA, as an investor.
Funny you claim to be an investor in biotech, but you are now giving your opinion on how you would trade MSB; sell after approval? Well you wouldn't have owned the stock cause you don't like speccy biotech. So maybe leave the traders to do what they know best and the investors to do what they do best.
Really pathetic, waiting for the pullback on the huge run up before giving your hindsightism to those who have risked trading/investing money, for maybe more than a decade (or maybe just even 12 months who took a very well skewed risk/reward trade sub 40c).
LOL, I expect the usual negative nellies to come out of their bomb shelter over the next week with much bravado and new stories/angles of why others should be selling their shares. Especially looking forward to the financial analyst clown who wants to value an early revenue biotech on PE and DCFs with no understanding of the science/regulatory/medical field.
Guys, the War has been lost. Just that some of the battalions haven't heard from Central Command due to communications being down. Keep fighting the good fight. LOL. I would like to say its admirable but sadly I believe its pathetic, arrogant, gutless, dishonorable and dishonest, at best embarrassingly ignorant.
MSB Price at posting:
$2.42 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)